sarcosine has been researched along with Multiple System Atrophy in 3 studies
cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis
Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oligodendroglial cytoplasmic inclusions composed of alpha-synuclein filamentous aggregates are the pathological hallmark of multiple system atrophy (MSA)." | 7.72 | Annular alpha-synuclein species from purified multiple system atrophy inclusions. ( Gai, WP; Lowe, R; Pountney, DL; Quilty, M; Vickers, JC; Voelcker, NH, 2004) |
| "Neuronal and glial cytoplasmic inclusions (NCIs and GCIs), which contain alpha-synuclein as a major component, are characteristic cytopathological features of multiple system atrophy (MSA)." | 7.71 | Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. ( Hasegawa, M; Hayashi, S; Ishikawa, A; Iwatsubo, T; Piao, YS; Takahashi, H; Wakabayashi, K; Yamada, M; Yoshimoto, M, 2001) |
| "Oligodendroglial cytoplasmic inclusions composed of alpha-synuclein filamentous aggregates are the pathological hallmark of multiple system atrophy (MSA)." | 3.72 | Annular alpha-synuclein species from purified multiple system atrophy inclusions. ( Gai, WP; Lowe, R; Pountney, DL; Quilty, M; Vickers, JC; Voelcker, NH, 2004) |
| "Neuronal and glial cytoplasmic inclusions (NCIs and GCIs), which contain alpha-synuclein as a major component, are characteristic cytopathological features of multiple system atrophy (MSA)." | 3.71 | Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration. ( Hasegawa, M; Hayashi, S; Ishikawa, A; Iwatsubo, T; Piao, YS; Takahashi, H; Wakabayashi, K; Yamada, M; Yoshimoto, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Woerman, AL | 1 |
| Kazmi, SA | 1 |
| Patel, S | 1 |
| Freyman, Y | 1 |
| Oehler, A | 1 |
| Aoyagi, A | 1 |
| Mordes, DA | 1 |
| Halliday, GM | 1 |
| Middleton, LT | 1 |
| Gentleman, SM | 1 |
| Olson, SH | 1 |
| Prusiner, SB | 1 |
| Pountney, DL | 1 |
| Lowe, R | 1 |
| Quilty, M | 1 |
| Vickers, JC | 1 |
| Voelcker, NH | 1 |
| Gai, WP | 1 |
| Piao, YS | 1 |
| Hayashi, S | 1 |
| Hasegawa, M | 1 |
| Wakabayashi, K | 1 |
| Yamada, M | 1 |
| Yoshimoto, M | 1 |
| Ishikawa, A | 1 |
| Iwatsubo, T | 1 |
| Takahashi, H | 1 |
3 other studies available for sarcosine and Multiple System Atrophy
| Article | Year |
|---|---|
MSA prions exhibit remarkable stability and resistance to inactivation.
Topics: alpha-Synuclein; Animals; Biological Transport; Brain; Detergents; Disease Models, Animal; Fixatives | 2018 |
Annular alpha-synuclein species from purified multiple system atrophy inclusions.
Topics: alpha-Synuclein; Brain Chemistry; Cholic Acids; Detergents; Humans; Inclusion Bodies; Macromolecular | 2004 |
Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
Topics: Aged; alpha-Synuclein; Brain; Cytoplasm; Female; Gliosis; Humans; Immunoblotting; Immunohistochemist | 2001 |